Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684526 · ClinicalTrials.gov registry record · NA
Is Eovist Suitable for Arterial-Phase MR Imaging of Liver
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 198
- Enrollment target
NCT02684526 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 198 participants.
The verdict
NCT02684526, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
Study Summary
To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.
Interventions
- PROCEDURE Eovist Contrast
- PROCEDURE Non Eovist Contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2011-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02684526
The ClinicalTrials.gov registry entry for NCT02684526 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Eovist Contrast is the first listed.
NCT02684526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02684526 about?
NCT02684526 is a clinical study titled "Is Eovist Suitable for Arterial-Phase MR Imaging of Liver". To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.
What is the current status of trial NCT02684526?
This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2011-12. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02684526?
The interventions under investigation include: Eovist Contrast (PROCEDURE), Non Eovist Contrast (PROCEDURE).
Who is sponsoring clinical trial NCT02684526?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.